Invega Sustenna 75mg (Paliperidone palmitate Vials) 75 mg

Invega Sustenna 75mg is an injectable antipsychotic medication designed to manage symptoms of schizophrenia and schizoaffective disorder. This extended-release formulation provides steady medication levels over time. Ideal for patients seeking consistent symptom control with fewer daily doses.

Strength

75 mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Janssen pharmaceutica NV

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Invega Sustenna 75mg is primarily used to treat schizophrenia, a mental health condition causing hallucinations, delusions, and disordered thinking. It is also prescribed for schizoaffective disorder, which combines schizophrenia symptoms with mood disorder elements like depression or mania. The medication helps stabilize mood and reduce psychotic episodes.

Side Effects

Users may experience a gradual reduction in symptoms such as agitation, paranoia, or disorganized speech over several weeks. Some report improved sleep patterns and reduced anxiety as the medication takes effect. Individual responses vary, and noticeable changes often develop with consistent use.

Precautions & Warnings

Store Invega Sustenna 75mg at room temperature, away from moisture and direct light. Keep out of reach of children and pets. Avoid freezing or exposing the vials to extreme heat. Always check the expiration date before use and dispose of unused medication properly.

Avoid Interactions

Alcohol may increase drowsiness or dizziness when combined with this medication. Certain medications, such as strong CYP3A4 inhibitors or inducers, can affect how Invega Sustenna works. Inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using.

Frequently Asked Questions

Invega Sustenna 75mg is used to treat schizophrenia and schizoaffective disorder by helping to manage symptoms like hallucinations and mood swings.

Symptom improvement may take several weeks, with some effects noticed gradually as the medication builds in your system.

Alcohol may increase drowsiness or dizziness; consult your healthcare provider for personalized advice.

No, Invega Sustenna is an extended-release injection typically given once monthly, reducing the need for daily pills.

Store at room temperature, away from moisture and direct light, and keep out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.